Ryusuke Hori

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

Locally Advanced

Patient Reported

Chronic Kidney Disease

Radiation Therapy

Top Venues

The Laryngoscope

Medicina (Kaunas, Lithuania)

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Atsushi Taguchi, Shintaro Fujimura, Yusuke Okanoue, Hiroki Kagoshima, Koki Hasebe, Hirotaka Yamamoto, Ryusuke Hori
Open wound management following pull-through resection for oral cancer: A case series of 14 patients. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2021)
Masahiro Kikuchi, Hiroyuki Harada, Ryo Asato, Kiyomi Hamaguchi, Hisanobu Tamaki, Masanobu Mizuta, Ryusuke Hori, Shintaro Fujimura, Keigo Honda, Takashi Tsujimura, Yohei Kumabe, Kazuyuki Ichimaru, Yoshiharu Kitani, Koji Ushiro, Morimasa Kitamura, Shogo Shinohara, Koichi Omori
Lingual Lymph Node Metastases as a Prognostic Factor in Oral Squamous Cell Carcinoma-A Retrospective Multicenter Study. Medicina (Kaunas, Lithuania) 57 (4) (2021)
Shintaro Fujimura, Koki Hasebe, Shintaro Fujimura, Yusuke Okanoue, Hiroki Kagoshima, Atsushi Taguchi, Hirotaka Yamamoto, Kazuhiko Shoji, Ryusuke Hori
A New iPhone Application for Voice Quality Assessment Based on the GRBAS Scale. The Laryngoscope 131 (3) (2020)
Atsushi Taguchi, Shintaro Fujimura, Yusuke Okanoue, Hiroki Kagoshima, Koki Hasebe, Hirotaka Yamamoto, Ryusuke Hori
A New Device for Fine-Needle Aspiration Cytology Consisting of a Vibrating Linear Resonant Actuator. The Laryngoscope 131 (4) (2020)
Ryusuke Hori, Shogo Shinohara, Shintaro Fujimura, Hiroki Kagoshima, Morimasa Kitamura, Ichiro Tateya, Hisanobu Tamaki, Yohei Kumabe, Ryo Asato, Hiroyuki Harada, Yoshiharu Kitani, Takashi Tsujimura, Keigo Honda, Kazuyuki Ichimaru, Koichi Omori
Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck Carcinoma. Cancers 11 (9) (2019)